Nancy Pelosi’s Latest AI Stock Pick Tempus AI Is Up Big Today

Source Domain: www.aol.com

Tempus AI’s stock surged about 44% following its acquisition of Ambry Genetics for $600 million, comprising $375 million in cash and $225 million in shares.
Despite a drop from a high of $91.45 to $68, and subsequent recovery, insiders like CFO Jim Rogers sold over 31,000 shares for about $2.6 million, though the sell-off isn’t viewed as significantly concerning by investors.
Notable political figures, including Nancy Pelosi, are bullish on Tempus AI by purchasing options, as well as Cathie Wood’s ARK Invest, which added 3.14 million shares at the end of 2024, increasing its stake by 132%.
Strong institutional interest continues, with significant increases in stakes by firms like Jane Street Group, Citadel Advisors, and Balyasny Asset Management. BlackRock also increased its stake by 445,900 shares.
Analysts at TD Cowen maintain a buy rating with a $74 price target, and Tempus AI is set to share its AI healthcare innovations and outlook at TD Cowen’s 45th Annual Health Care Conference in early March.

You may have missed